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bstract
ntroduction:  The problems associated with clinical trial participation have been highlighted in the literature, but few studies have examined why
atients decline to participate.
ims:  To describe non-participants’ and participants’ characteristics and examine reasons for non-participation in a pragmatic trial of energy
ealing for rehabilitation for colorectal cancer.
ethods:  Three to seven days after postal recruitment, all eligible participants (n  = 783) were contacted by telephone. Reasons given for non-
articipation were recorded in 5 categories. Data were analyzed using Chi2.
esults:  More men than women declined to participate (men = 55.7%; women = 44.3%; p  = 0.022). Non-participants were on average older than
articipants (non-participants: mean age 68.4; SD (9); participants: mean age 64; SD (8.8); p  < 0.001), and had only received surgery (non-
articipants = 54.1%; participants = 40.1%; p  < 0.001). The most frequent reasons for non-participation were (1) No need for rehabilitation (n  = 81;
8.6%), (2) participation too burdensome (n  = 67; 23.7%), and (3) no interest in energy healing (n  = 57; 20.1%). If the time span between study
ecruitment and surgery was 0–9 months, participation was frequently considered too burdensome (p  = 0.020), especially by women (n  = 45;
7.2%; p  = 0.001) and those aged ≥68 (n  = 54; 80.6%; p  = 0.013); rehabilitation was frequently considered not needed 10–17 months after surgery
p  = 0.035).
onclusion:  Non-participation in a trial of energy healing as rehabilitation for colorectal cancer revealed an interplay between non-participants’
emographic characteristics, health experiences, everyday life priorities and the offered rehabilitation intervention. To optimize recruitment to
tudies of cancer rehabilitation, consideration of disease trajectories and potential participants’ rehabilitation needs is suggested.
 2014 The Authors. Published by Elsevier GmbH. This is an open access article under the CC BY-NC-ND license
http://creativecommons.org/licenses/by-nc-nd/3.0/).
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ackgroundIn 2012, colorectal cancer was estimated to be the second
ost common form of cancer diagnosed in Europe and the sec-
nd most common form of death from cancer [1]. Diagnosis and
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reatment of colorectal cancer has significant impact on people’s
ives. People with colorectal cancer experience poor quality of
ife following surgery and treatment [2], and continue to experi-
nce side-effects after treatment [3–5]. Colorectal cancer-related
ymptoms include fatigue, digestive problems, memory lapses,
exual problems, lack of concentration, and sleep interruptions
5]. These and other symptoms may make daily activities diffi-
ult [6,7].Complementary alternative medicine (CAM) is widely used
y cancer patients [8–11], including in colorectal cancer [12],
nd is commonly combined with biomedical treatment [13–16].
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tion “as usual” was accepted, but no other form of therapy than
energy healing was allowed.M. Techau et al. / European Journal 
mongst cancer patients, energy healing is one of the ten most
hosen therapies for CAM cancer care in Europe [16] and used
y up to 10% of cancer patients in Denmark [14].
In 2011–2012, a pragmatic trial on energy healing as rehabil-
tation for colorectal cancer was conducted in Denmark in order
o test guidelines for effectiveness studies measuring person-
lized goals of treatments [17–20]. Considerable efforts were
ade to enlist participants for the trial, based on strategies
o increase trial participation examined in the literature [e.g.
1–23], such as the inclusion of a pre-paid envelope and follow-
p contact by telephone. Despite these efforts, only 31.5% of
ligible participants responded. The aim of this article is to
ontrast non-participants’ and participants’ characteristics and
xamine non-participants’ reasons for declining to take part in
he trial. Although the problems associated with trial partici-
ation have been highlighted in the literature [e.g. 24–26], few
tudies have examined why patients refuse to participate in clin-
cal trials [24]. This article provides insights into motivations
nd reasons that underpin non-participation in a pragmatic trial
f energy healing as cancer rehabilitation.
ethods
ecruitment  of  patient  participants
Based on an extraction from the Danish National Patient Reg-
stry a total of 783 persons were considered eligible to participate
n the trial. Eligibility criteria included: (1) primary diagnosis of
olorectal cancer, defined as C18–C20, according to the Inter-
ational Classification of Diseases (ICD10); (2) treated with
urgery or surgery combined with chemotherapy and/or radio-
herapy in the Southern or Central Region of Denmark between
 March 2010, and 1 August 2011, and without evidence of
urrent cancer; and (3) aged ≤  80 at study inclusion. Patients
ere excluded if they: (1) were unable to comply with the data
ollection protocol, (2) had poor understanding of the Danish
anguage, or (3) were receiving palliative care or had a recurrence
f cancer prior to inclusion.
Using a centralized, computerized procedure, Minim (Mini-
ization Program for Allocating Patients to Treatments in
linical Trials), eligible participants were randomly stratified
ccording to gender into a self-selection arm or a randomization
rm prior to initial contact. This randomization design, based
n energy healing versus no treatment, was chosen because of
he primary hypothesis that patients who self-select the energy
ealing intervention will experience greater effects for primary
utcomes than patients who are randomized to the interven-
ion. This design also makes it possible to examine whether
here might be a relationship between trial participation or non-
articipation and allocation to randomization or self-selection
rms.
Eligible participants were mailed a folder containing: writ-
en information about the study; a leaflet containing information
bout the healers in the study; an informed consent form; a pre-
aid envelope; and the first part of a questionnaire package.
he accompanying letter differed, depending whether recipients
ere allocated to the self-selection arm or the randomization
e
u
ogrative Medicine 6 (2014) 268–276 269
rm. Recipients in the self-section arm were informed that they
ould choose between treatments with energy healing and allo-
ation to the control group. Recipients in the randomization arm
ere informed that they would be allocated either to receive
nergy healing or to be in the control group. Participants not
eceiving the energy healing intervention during the trial were
ffered one free treatment with an energy healer after trial com-
letion; this was taken up by one participant only (for details of
ecruitment and randomization, see Fig. 1).
Three to seven days after the mailed invitation, two research
ssistants made telephone calls to all eligible participants
n = 783) in order to answer any possible questions concern-
ng the study, exclude potential participants who did not fulfill
he inclusion criteria (such as known recurrence of cancer), and
o ask for possible reasons if participation was declined. Ques-
ions such as ‘do you have a particular reason for not wanting
o participate?’ and ‘why do you not want to participate in this
rial’ guided the elicitation of reasons for non-participation, if
o reasons had been forthcoming during the earlier part of the
onversation. The elicited primary reason (one reason per per-
on only), was immediately recorded in a non-participation log,
ccording to six topics: (1) does not wish to participate in a trial
f CAM or energy healing, (2) does not have the vitality, strength
r energy to participate in such an extensive trial, (3) does not
ish to use time on any trial participation, (4) does not like to
e in randomization arm of trial, (5) rehabilitation not relevant,
s the respondent is well and does not want to focus on illness
ny longer, and (6) cannot complete questionnaires, find trans-
ort, and similar. These six topics derived from engagement with
iterature about trial participation [for example, 21–24,26] and
he interest to establish whether the therapy of energy healing
mpacted on non-participation.
If an eligible participant had not returned the questionnaire
ithin 2–4 weeks a reminder call was made, following the same
bove procedure; hereafter no-response was considered non-
articipation. A total of 247 individuals participated in the study
response rate 31.5%; men n  = 115, 46.6%; women n = 132,
3.4%).
ntervention  procedure
The intervention consisted of four sessions of energy heal-
ng spread over a 2-months period; the distribution of sessions
as decided by each participant-healer2 pair. Patient participants
hose one of the participating healers, and the energy healing
essions took place at the healers’ clinic. The energy healing
elivered was not restricted to a specific form of energy heal-
ng, provided that it was based on the general idea of the healer
ransmitting some kind of “energy” to the participant. Conversa-2 Healers were identified and recruited through a national association of heal-
rs (‘Healer-Ringen’). Additional inclusion criteria were: (1) treatment facilities
sed solely for the practice of healing, and (2) clinic location within the regions
f Central and Southern Denmark. A total of 31 healers were included.
270 M. Techau et al. / European Journal of Integrative Medicine 6 (2014) 268–276
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atasets
All participants were asked to complete questionnaires at
ve points during the study (see Fig. 2): at inclusion (T1); ten
ays after inclusion and before the start of treatment (T2, base-
ine); 4–6 weeks after baseline (T3, in connection with the third
reatment for those who received energy healing); 8 weeks after
aseline (T4, after the last treatment); and 16 weeks after base-
ine (T5, two months post-treatment). Questionnaires included
he Measure Yourself Concern and Wellbeing questionnaire
MYCaW) and a range of standardized validated questionnaires
n, for example, quality of life, mood, sleep and depression. Fur-
her, all participants were asked to choose the most important
rea of concern on a priority list presenting seven overarch-
ng categories of concerns that were covered by the validated
uestionnaires: cancer related symptoms (including late effects
f cancer treatment), physical activity, quality of life, depres-
ive symptoms, mood, sleep quality, economy. A further option,
other concerns’, was included in the priority list.
Four qualitative semi-structured interviews lasting on average
ne hour were conducted at T2, T3, T4 and T5 with 32 partici-
ants selected strategically to cover a range of ages, occupations,
iving conditions and prior experience with complementary and
lternative medicine; one participant dropped out after the first
nterview, reducing the sample to 31 participants. The first and
ast interviews were conducted in the participants’ homes, and
he second and third interviews were carried out by telephone and randomization.
r Skype. Furthermore, at T2, T4 and T5, 65 participants com-
leted a diary in which they recorded their daily activities on an
ourly basis over five days.
thics
The study adhered to the ethical requirements of the Helsinki
eclaration. Participants received written and oral information
bout the study, and were informed that they were free to with-
raw from the study at any time during the study period. The
tudy was presented to the regional Committee of Research
thics in Southern Denmark; the Committee decided that the
tudy did not require their approval. The study has been approved
y the Danish Data Protection Agency.
nalysis  of  non-participant  log
Responses were analyzed and the following categories estab-
ished:
1) No need for rehabilitation (based on expressions of being
well and/or having physically, emotionally and mentally
adapted to the cancer experience)
2) Study participation physically, emotionally and/or mentally
too burdensome (based on expressions of wanting to attend
to issues related to the cancer experience, other health-
related concerns or everyday life priorities)
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3) No interest in energy healing, for example as a form of
therapy in rehabilitation
4) No time for study participation (based on expressions of
being busy with professional and social engagements and
commitments)
5) Other (for example, not wanting to participate in any
research; feeling too old; dissatisfaction with allocation to
randomization arm [one response only])
After contact with the first 50 potential participants, these
ategories were reassessed and confirmed as useful after slight
odifications.
tatistical  analysis
All data were analyzed using the Statistical Package for
ocial Sciences (SPSS), version 19. Descriptive statistics were
alculated with all variables to summarize the data. Differ-
nces in socio-demographic characteristics between the different
opulations were assessed using the Chi2 test.
esults
The eligible recruitment population (n  = 783) comprised
2.6% men (n  = 412) and 47.4% women (n  = 371), aged 29–80
mean age 66.9); 94 (12%) eligible participants were excluded.
t the end of the recruitment period 56.5% (n  = 442) of the eli-
ible recruitment population were considered non-participants,
esulting in a non-participation rate of 68.5% (see Fig. 3).
on-participants’  characteristics
Of the non-participants, 55.7% (n  = 246) were men and 44.3%
n = 196) were women.
Mean age was 68.4 (age 29–80), with a majority (n  = 272)
ged ≥  68; men and women were distributed nearly equally
etween those aged ≤  67 and those aged ≥  68 (X2(df1) = 1.579;
 = 0.209). The majority of non-participants (n  = 239; 54.1%)
ad undergone surgery only (see Table 1).
articipants’  characteristicsOf the participants, 53.4% (n  = 132) were women and 46.6%
n = 115) were men. Mean age was 64 (age 36–80), with near
qual distribution of those aged ≤  64 and those aged ≥  65; more
(
t
i
w line.
omen (n  = 76; 30.8%) were in the younger age group and more
en (n  = 71; 28.7%) in the older age group (X2(df1) = 9.178;
 = 0.002). The majority of participants (n  = 148; 59.9%) had
eceived chemotherapy and/or radiotherapy in addition to
urgery (see Table 1).
omparison  between  non-participants’  and  participants’
haracteristics
Amongst the non-participants were slightly more men than
omen (men: n  = 246, 55.7%; women: n  = 196, 44.3%), com-
ared to the study participants (men: n = 115, 46.6%; women:
 = 132, 53.4%; p  = 0.022). The mean age of non-participants
as 68.4, compared to participants’ mean age of 64, making
he non-participants overall older than participants (p < 0.001).
ore than half of the non-participants had received only surgery,
hile more than half of participants had received chemotherapy
nd/or radiotherapy in addition to surgery (p  < 0.001). Accord-
ngly, non-participants were more likely to be men who had only
eceived surgery, with a mean age of 68.4. No further differences
oncerning study recruitment since surgery (p  = 0.909) or distri-
ution to randomization or self-selection arms (p  = 0.175) can
e detected (see Table 1).
easons  for  non-participation
Reasons to decline study participation are known for 64%
n = 283) of non-participants (see Fig. 3); 20.1% (n = 89) eligi-
le participants who had not responded to the invitation letter
ould not be contacted by telephone; 15.8% (n = 70) had been
ontacted but were undecided at the time and in the event did not
articipate and their reasons for non-participation are unknown.
t is the 283 non-participants’ primary reasons not to take part
n the study that are examined here.
This sample of non-participants is characterized by near equal
ender distribution (women n = 138; men 145), with 68.2%
n = 193) aged ≥  68; 55.1% (n  = 156) had received only surgery
ith near equal division across the time spans since surgery;
3% (n  = 150) were in the randomization arm (see Table 2).
The most frequently given primary reason for non-
articipation was that there was ‘no need for rehabilitation’
n = 81, 28.6%), followed by the perception that study participa-
ion would be ‘too burdensome’ (n  = 67, 23.7%) and ‘no interest
n energy healing’ (20.1%, n  = 57) (see Table 2). In particular,
omen and those aged ≥  68 conveyed that study participation
272 M. Techau et al. / European Journal of Integrative Medicine 6 (2014) 268–276
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as too burdensome (n  = 45, 67.2%, p = 0.001; n  = 54, 80.6%,
 = 0.013 respectively), and the majority who expressed a lack of
nterest in energy healing were men (n  = 35, 61.4%, p  = 0.086).
urthermore, particularly men (n  = 10; 71.4%; p  = 0.121) and
hose aged ≤  67 (n  = 9; 64.3%; p  = 0.007) mentioned not to have
ime for participation (see Table 2). Table 2 also indicates that
o significant differences were found with regard to distribu-
ion into randomization or self-selection arms, although 78.6%
n = 11, p = 0.049) of non-participants who expressed to not have
ime for participation were in the randomization arm.
As Fig. 4 indicates, there appears to be a relationship between
he time span since cancer surgery and recruitment to the
rial on the one hand, and the categories ‘participation too
urdensome’ and ‘no need for rehabilitation’ on the other.
f recruitment took place 0–9 months since surgery, invita-
ion to the trial frequently seemed to be perceived as ‘too
urdensome’ (X2(df3) = 9.851, p  = 0.020, Cramer’s V  = 0.187),
specially by women (n  = 45; 67.2%; p  = 0.001) and those
ged ≥ 68 (n  = 54; 80.6%; p  = 0.013). By contrast, if recruit-
ent took place 10–17 months since surgery, participation in
he trial frequently seemed to be ‘not needed’ (X2(df3) = 8.626,
T
p
r
tsons for non-participation.
 = 0.035, Cramer’s V  = 0.175). Time span since surgery did not
eem to have implications concerning the other categories.
iscussion
This article described the characteristics of non-participants
nd participants in a pragmatic trial of energy healing as
ehabilitation in colorectal cancer, and examined reasons for
on-participation. Findings indicate that in our sample of non-
articipants (n  = 422), non-participants were more likely to be
en (n  = 246, 55.7%) with a mean age of 68.4 who had only
eceived surgery. By contrast, participants were more likely
o be women (53.4%; n = 132), with a mean age of 64, and
ad received chemotherapy and/or radiotherapy in addition to
urgery (n  = 148; 59.9%).
Based on semi-structured telephone interviews, this arti-
le also investigated individuals’ reasons for non-participation.
he exploration of non-participants’ primary reasons to decline
articipation in a trial of energy healing as rehabilitation for colo-
ectal cancer reveals a complex interplay between gender, age,
ime span since completion of cancer-related treatment, health
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Table 1
Non-participant and participant characteristics.
Non-participants Participants p  value
N = 442, N(%) N = 247, N(%)
Gender
Women 196 (44.3) 132 (53.4) X2(df1) = 5.258
p = 0.022aMen 246 (55.7) 115 (46.6)
Age Range [29–80]
Mean 68.42; SD[8.998]
Range [36–80]
Mean 64.06; SD[8.842]
X2(df1) = 31.586
p < 0.001a
≤67 years 170 (38.7) 150 (60.7)
≥68 years 272 (61.5) 97 (39.3)
Cancer treatment Range [0–115; numbers of
chemo/radio treatments]
Mean 11.07; SD [19.775]
Range [0–116; numbers of
chemo/radio treatments]
Mean 14.02; SD [21.857]
Surgery 239 (54.1) 99 (40.1) X2(df1) = 12.412
p < 0.001aSurgery + chemo/radio 203 (45.9) 148 (59.9)
Months since surgery
0–5 months 107 (24.2) 54 (21.9) X2(df3) = 0.544
p  = 0.909
Cramers
value = 0.028
6–9 months 106 (24.0) 61 (24.7)
10–13 months 115 (26.0) 68 (27.5)
14–17 months 114 (25.8) 64 (25.9)
Randomization/self-selection
Randomization 226 (51.1) 113 (45.7) X2(df1) = 1.837
S
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telf-selection 216 (48.9) 
a Significant p value in bold.
nd other needs and priorities, and the status of energy heal-
ng for cancer care. The most frequent primary reason (28.6%)
or non-participation given by respondents was that they had
o need for rehabilitation, indicating that they were well and/or
ad adapted physically, emotionally and mentally to their can-
er experience. This can be seen in light of the trial inclusion
riteria, which recruited participants who had completed cancer-
elated hospital treatment within the past 18 months prior to
tudy inclusion. On the other hand, 23.7% of non-participants,
articularly women and those aged ≥  68, considered participa-
ion as too burdensome, given their cancer-related and/or overall
ealth needs and priorities concerning their everyday lives. This
ight imply that the extent of poor quality of life and/or side
ffects experienced as a result of colorectal cancer and its treat-
ent [2–5] may continue to have significant limiting impact
i
e
p
Fig. 4. Categories ‘participation too burdensome’ and ‘no neep = 0.175134 (54.3)
n these respondents’ everyday life [6,7], leading to decline
articipation in research. Practical issues relating to trial par-
icipation, and the commitment required in terms of time and
ffort may also lead to participation being perceived as a burden
24,26,27]. In addition, 80.6% of those perceiving participa-
ion as too burdensome where aged ≥  68; this may confirm
he tendency that CAM use in Denmark decreases with age
28].
A significant number of respondents (20.1%), particularly
en (61.4%), declined participation due to a lack of inter-
st in energy healing as a form of rehabilitation. This reflects
he general trend that more women than men use CAM [13],
ncluding for cancer in Denmark [14,28]. Furthermore, while
nergy healing is amongst the most frequently used thera-
ies for CAM cancer care in Europe [16] and one of the
d for rehabilitation’ relative to time span since surgery.
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Table 2
Primary reasons for non-participation (n = 283).
All primary reasonsa No need for
rehabilitationb
Participation too
burdensomeb
No interest in energy
healingb
No time for
participationb
Otherb
N = 283 (100%),
N (%)
N  = 81(28.6% of
n  = 283), N (%)
N = 67(23.7% of
n = 283), N (%)
N = 57(20.1% of
n = 283), N (%)
N = 14(4.9% of
n = 283), N (%)
N = 64(22.6% of
n  = 283), N (%)
Gender
Women 138 (48.8) 42 (51.9) 45 (67.2) 22 (38.6) 4 (28.6) 25 (39.1)
Men 145 (51.2) 39 (48.1) 22 (32.8) 35 (61.4) 10 (71.4) 39 (60.9)
p value X2(df4) = 16.442
p = 0.002c
X2(df1) = 0.433
p = 0.510
X2(df1) = 11.896
p = 0.001
X2(df1) = 2.953
p = 0.086
X2(df1) = 2.487
p = 0.121
X2(df1) = 3.115
p  = 0.078
Age
≤67 years 90 (31.8) 23 (28.4) 13 (19.4) 23 (40.4) 9 (64.3) 22 (34.4)
≥68 years 193 (68.2) 58 (71.6) 54 (80.6) 34 (59.6) 5 (35.7) 42 (65.5)
p value X2(df4) = 14.110
p  = 0.007
CVd = 0.223
X2(df1) = 0.607
p = 0.436
X2(df1) = 6.222
p = 0.013
X2(df1) = 2.405
p = 0.121
X2(df1) = 7.166
p = 0.007
X2(df1) = 0.252
p  = 0.615
Cancer treatment
Surgery 156 (55.1) 47 (58) 38 (56.7) 31 (54.4) 4 (28.6) 36 (56.3)
Surgery + chemo/radio 127 (44.9) 34 (42) 29 (43.3) 26 (45.6) 10 (71.4) 28 (43.8)
p value X2(df4) = 4.380
p  = 0.357
CV = 0.124
X2(df1) = 0.386
p = 0.534
X2(df1) = 0.090
p = 0.764
X2(df1) = 0.016
p = 0.900
X2(df1) = 4.198
p = 0.040
X2(df1) = 0.042
p  = 0.837
Months since surgery
0–5 months 72 (25.1) 21 (25.9) 21 (31.3) 17 (29.8) 3 (21.4) 9 (14.1)
6–9 months 67 (23.7) 10 (12.3) 22 (32.8) 11 (19.3) 4 (28.6) 20 (31.3)
10–13 months 72 (25.4) 25 (30.9) 9 (13.4) 19 (33.3) 4 (28.6) 15 (23.4)
14–17 months 73 (25.8) 25 (30.9) 15 (22.4) 10 (17.5) 3 (21.4) 20 (31.3)
p value X2(df12) = 23.412
p = 0.024
CV = 0.166
X2(df3) = 8.626
p = 0.035
CV = 0.175
X2(df3) = 9.851
p = 0.020
CV = 0.187
X2(df3) = 4.847
p = 0.183
CV = 0.131
X2(df3) = 0.016
p = 0.900
CV = 0.037
X2(df3) = 7.097
p  = 0.069
CV = 0.158
Randomization/self-selection
Randomization 150 (53.0) 42 (51.9) 35 (52.2) 33 (57.9) 11 (78.6) 29 (45.3)
Self-selection 133 (47.0) 39 (48.1) 32 (47.8) 24 (42.1) 4 (21.4) 35 (54.7)
p value X2(df4) = 5.800
p  = 0.215
CV = 0.143
X2(df1) = 0.060
p = 0.806
X2(df1) = 0.021
p = 0.886
X2(df1) = 0.686
p = 0.408
X2(df1) = 3.865
p = 0.049
X2(df1) = 1.964
p  = 0.161
a Chi2-statistics comparing the primary reasons for non-participation with gender, age, cancer treatment, months since surgery, and randomization/self-selection.
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d Cramer’s value.
ost used forms of CAM in Denmark [29] only 7% of the
anish population have ever used this therapy [29], and up to
0% of cancer patients use it in cancer care [14]. This rela-
ively low interest in energy healing for cancer is therefore also
eflected in our finding of limited interest in energy healing for
ehabilitation in colorectal cancer; it also confirms Richardson et
l’s [26] finding that 24.3% of women respondents lacked inter-
st to participate in a trial of CAM after breast cancer. Lastly,
n our study particularly men and those aged ≤  67 (4.9%) men-
ioned the lack of time for research participation, pointing to
he possibility that male and/or younger respondents may have
aken up professional and/or social commitments again follow-
ng the completion of cancer-related hospital treatment. In sum,
on-participation in clinical trials is a complex phenomenon
hat is grounded in an interplay between non-participants’
c
h
bge, cancer treatment, months since surgery, and randomization/self-selection.
emographic characteristics, health experiences, everyday life
riorities and the offered rehabilitation intervention.
Identifying the most suitable time to recruit trial partici-
ants in investigations of rehabilitation interventions is critical.
ur findings highlight that in the earlier months (months
–9) following completion of treatment for colorectal cancer
rial participation may be considered to be ‘too burdensome’,
hile immediately after treatment completion (months 0–5),
ancer rehabilitation may possibly be perceived as ‘not yet
eeded’. On the other hand, study recruitment after a longer
ime span since treatment (months 10–17), and accommoda-
ions possibly to have been made to the cancer experience and
ancer-related symptoms, rehabilitation interventions may per-
aps be perceived as ‘not needed any  longer’ or also as ‘too
urdensome’ to be fitted into everyday life commitments and
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outines. These findings point to the importance of consider-
ng study recruitment in the contexts of disease trajectories and
otential participants’ rehabilitation needs [30], as well as the
eneral barriers and facilitators of clinical trial recruitment, such
s demands on time, work schedules, transport and childcare
ssues, and the wish to forget illness experiences [24–26].
Inevitably, there are limitations to this study. Although an
nvestigation of non-participation was intended from the incep-
ion of the trial, it constituted only a small sub-study. Therefore,
nly selected factors known to influence trial participation and
on-participation were explored when asking potential partic-
pants about their reasons for non-participation. Further, the
tudy of non-participation presented here was part of a complex
ross-disciplinary trial that called for extensive input and time-
onsuming commitments from trial participants over a lengthy
eriod of time. This may be reflected in the high number of
esponses that perceived participation to be too burdensome.
astly, for purposes of comparison it would have been relevant
o also investigate participants’ reasons for participation in the
rial.
onclusion
The exploration of non-participants’ characteristics and rea-
ons for non-participation in a pragmatic trial of energy healing
s rehabilitation in colorectal cancer demonstrates an inter-
lay between demographic characteristics, health experiences
nd needs, everyday life priorities and the offered rehabilita-
ion intervention. More men than women declined participation;
on-participants were on average older than participants and had
eceived only surgery. Participation was frequently declined on
he grounds of trial participation being too burdensome (espe-
ially 0–9 months after surgery), rehabilitation not being needed
especially 10–17 months after surgery), and a lack of interest
n energy healing. To optimize recruitment to trials of cancer
ehabilitation, consideration of disease trajectories and potential
articipants’ rehabilitation needs, together with general barriers
nd facilitators of trial participation is suggested.
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